稳定胸痛患者:CT冠状动脉造影与有创冠状动脉造影的比较
DISCHARGE是一项在26个欧洲中心开展的实用性随机试验,纳入因稳定胸痛、阻塞性冠心病验前概率中等而被转诊行有创冠状动脉造影的3561例患者(女性56.2%),比较CT与有创冠状动脉造影作为初始诊断影像策略指导治疗的效果。3.5年内主要不良心血管事件(心血管死亡、非致死性心肌梗死或非致死性卒中)在CT组1808例中发生38例(2.1%),在有创造影组1753例中发生52例(3.0%)(HR 0.70;95%CI 0.46–1.07;P=0.10)。主要操作相关并发症CT组9例(0.5%)显著低于有创造影组33例(1.9%)(HR 0.26;95%CI 0.13–0.55)。随访最后4周心绞痛发生率CT组8.8%、有创造影组7.5%(OR 1.17;95%CI 0.92–1.48)。
要点
- 稳定胸痛、阻塞性冠心病验前概率中等并被转诊行有创冠状动脉造影的患者,初始CT策略与初始有创造影策略的3.5年主要不良心血管事件风险相似(2.1% vs 3.0%;HR 0.70;95%CI 0.46–1.07;P=0.10)。
- 初始CT策略的主要操作相关并发症显著少于初始有创造影策略(0.5% vs 1.9%;HR 0.26;95%CI 0.13–0.55)。
- 随访最后4周心绞痛发生率CT组8.8% vs 有创造影组7.5%(OR 1.17;95%CI 0.92–1.48),差异未达统计学显著。
- 试验纳入3561例患者(女性56.2%),随访完整3523例(98.9%),在26个欧洲中心开展。
适用人群与场景
- 因稳定胸痛、阻塞性冠心病验前概率中等而被转诊行有创冠状动脉造影的患者,在26个欧洲中心纳入随机分组。
诊断标准与关键阈值
- 阻塞性冠心病验前概率为中等,并因稳定胸痛被转诊行有创冠状动脉造影。
处置流程与药物剂量
- 初始诊断影像策略随机分为CT或是有创冠状动脉造影,用以指导稳定胸痛患者的治疗。
研究设计与关键结果
- 实用性随机试验,纳入3561例患者(女性占56.2%),随访完整3523例(98.9%),在26个欧洲中心开展。
- 主要终点为3.5年内主要不良心血管事件(心血管死亡、非致死性心肌梗死或非致死性卒中):CT组1808例中38例(2.1%)vs 有创冠状动脉造影组1753例中52例(3.0%),HR 0.70(95%CI 0.46–1.07),P=0.10。
- 主要操作相关并发症:CT组9例(0.5%)vs 有创冠状动脉造影组33例(1.9%),HR 0.26(95%CI 0.13–0.55)。
- 随访最后4周心绞痛:CT组8.8% vs 有创冠状动脉造影组7.5%,OR 1.17(95%CI 0.92–1.48)。
证据类型、等级与局限
- 实用性随机试验(DISCHARGE,ClinicalTrials.gov NCT02400229),由欧盟第七框架计划等资助。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对稳定胸痛、阻塞性冠心病验前概率中等且被转诊行有创冠状动脉造影的患者,初始CT策略与初始有创冠状动脉造影策略的主要不良心血管事件风险相似。
- 初始CT策略的主要操作相关并发症频率低于初始有创冠状动脉造影策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: In the diagnosis of obstructive coronary artery disease (CAD), computed tomography (CT) is an accurate, noninvasive alternative to invasive coronary angiography (ICA). However, the comparative effectiveness of CT and ICA in the management of CAD to reduce the frequency of major adverse cardiovascular events is uncertain.
METHODS: We conducted a pragmatic, randomized trial comparing CT with ICA as initial diagnostic imaging strategies for guiding the treatment of patients with stable chest pain who had an intermediate pretest probability of obstructive CAD and were referred for ICA at one of 26 European centers. The primary outcome was major adverse cardiovascular events (cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke) over 3.5 years. Key secondary outcomes were procedure-related complications and angina pectoris.
RESULTS: Among 3561 patients (56.2% of whom were women), follow-up was complete for 3523 (98.9%). Major adverse cardiovascular events occurred in 38 of 1808 patients (2.1%) in the CT group and in 52 of 1753 (3.0%) in the ICA group (hazard ratio, 0.70; 95% confidence interval [CI], 0.46 to 1.07; P = 0.10). Major procedure-related complications occurred in 9 patients (0.5%) in the CT group and in 33 (1.9%) in the ICA group (hazard ratio, 0.26; 95% CI, 0.13 to 0.55). Angina during the final 4 weeks of follow-up was reported in 8.8% of the patients in the CT group and in 7.5% of those in the ICA group (odds ratio, 1.17; 95% CI, 0.92 to 1.48).
CONCLUSIONS: Among patients referred for ICA because of stable chest pain and intermediate pretest probability of CAD, the risk of major adverse cardiovascular events was similar in the CT group and the ICA group. The frequency of major procedure-related complications was lower with an initial CT strategy. (Funded by the European Union Seventh Framework Program and others; DISCHARGE ClinicalTrials.gov number, NCT02400229.).
参考来源
- Maurovich-Horvat P, Bosserdt M, Kofoed KF, et al. CT or Invasive Coronary Angiography in Stable Chest Pain. N Engl J Med. 2022. PMID: 35240010. doi:10.1056/NEJMoa2200963
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。